Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy

Clinical trial NCT05388058 · COMPLETED

Trial details

NCT number: NCT05388058
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy-Induced Peripheral Neuropathy Malignant Solid Neoplasm

Start date: 2022-06-09
Primary completion: 2023-07-14
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.